相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rise and fall of lung cancers in relation to tobacco smoking and air pollution: A global trend analysis from 1990 to 2012
Steve H. L. Yim et al.
ATMOSPHERIC ENVIRONMENT (2022)
Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities?
Anamul Hasan et al.
MOLECULES (2022)
A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
Md. Al Saber et al.
PROCESSES (2022)
Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms
Md Sohel et al.
PROCESSES (2022)
Evaluation of in vitro and in silico anti-inflammatory potential of some selected medicinal plants of Bangladesh against cyclooxygenase-II enzyme
Md Aminul Islam et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer
Jakub Morze et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
Design, synthesis and antitumour evaluation of novel anthraquinone derivatives
Kai-Wei Lin et al.
BIOORGANIC CHEMISTRY (2021)
The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
Maiko Okano et al.
JOURNAL OF HUMAN GENETICS (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Metabolite profiling, anti-inflammatory, analgesic potentials of edible herb Colocasia gigantea and molecular docking study against COX-II enzyme
Md Nazmul Hasan Zilani et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study
Rasel Ahmed Khan et al.
MOLECULES (2021)
The impact of the Covid-19 pandemic on breast cancer early detection and screening
Jonine D. Figueroa et al.
PREVENTIVE MEDICINE (2021)
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
Victor M. Matias-Barrios et al.
FRONTIERS IN ONCOLOGY (2021)
Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential
Anna E. Kaiser et al.
CANCERS (2021)
Exhaustive Plant Profile of Dimocarpus longan Lour with Significant Phytomedicinal Properties: A Literature Based-Review
Priyanka Paul et al.
PROCESSES (2021)
Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis
Partha Biswas et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)
Ethnomedicinal Use, Phytochemistry, and Pharmacology of Xylocarpus granatum J. Koenig
Dipta Dey et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
In Vivo Neuropharmacological Potential of Gomphandra tetrandra (Wall.) Sleumer and In-Silico Study against β-Amyloid Precursor Protein
Md. Saidur Rahman et al.
PROCESSES (2021)
Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation
Partha Biswas et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
ANTIVIRAL EFFECTS OF BACTERIOCIN AGAINST ANIMAL-TO-HUMAN TRANSMITTABLE MUTATED SARS-COV-2: A SYSTEMATIC REVIEW
Dipta Dey et al.
FRONTIERS OF AGRICULTURAL SCIENCE AND ENGINEERING (2021)
Target specificity of selective bioactive compounds in blocking α-dystroglycan receptor to suppress Lassa virus infection: an in silico approach
Adittya Arefin et al.
JOURNAL OF BIOMEDICAL RESEARCH (2021)
Anticancer and antimicrobial peptides from medicinal plants of Borneo island in Sarawak
Hasnain Hussain et al.
ADVANCES IN TRADITIONAL MEDICINE (2021)
Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer Related Targets
Ziga Skok et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Ufuk Degirmenci et al.
CELLS (2020)
Perplexing Role of P-Glycoprotein in Tumor Microenvironment
Kianna Robinson et al.
FRONTIERS IN ONCOLOGY (2020)
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice (vol 10, 1614, 2020)
Amit S. Choudhari et al.
FRONTIERS IN PHARMACOLOGY (2020)
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
Souad Assaad et al.
EUROPEAN JOURNAL OF CANCER (2020)
Molecular Insights into the Multifunctional Role of Natural Compounds: Autophagy Modulation and Cancer Prevention
Md. Ataur Rahman et al.
BIOMEDICINES (2020)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Cell Cycle-Dependent Control and Roles of DNA Topoisomerase II
Joyce H. Lee et al.
GENES (2019)
Quantitative proteomics reveals mitochondrial respiratory chain as a dominant target for carbon ion radiation: Delayed reactive oxygen species generation caused DNA damage
Peng-Cheng Fan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
ROS and the DNA damage response in cancer
Upadhyayula Sai Srinivas et al.
REDOX BIOLOGY (2019)
Selectins in cancer immunity
Lubor Borsig
GLYCOBIOLOGY (2018)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaison
J. Ignacio Casal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
Yunxiao Meng et al.
CANCER LETTERS (2018)
Challenges and future direction of molecular research in air pollution related lung cancers
Maizatul Syafinaz Shahadin et al.
LUNG CANCER (2018)
Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
Amila K. Nanayakkara et al.
SCIENTIFIC REPORTS (2018)
LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and gamma-irradiation
E. Zulato et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Oxidative DNA damage induced by ROS-modulating agents with the ability to target DNA: A comparison of the biological characteristics of citrus pectin and apple pectin
Fahimeh Salehi et al.
SCIENTIFIC REPORTS (2018)
Cancers related to lifestyle and environmental factors in France in 2015
Isabelle Soerjomataram et al.
EUROPEAN JOURNAL OF CANCER (2018)
Anticancer Activity of Natural Compounds from Plant and Marine Environment
Anna Lichota et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Jonathan P. McNally et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Redox-sensitive alteration of replisome architecture safeguards genome integrity
Kumar Somyajit et al.
SCIENCE (2017)
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori et al.
ADVANCED PHARMACEUTICAL BULLETIN (2017)
ROS and ROS-Mediated Cellular Signaling
Jixiang Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells
Feifei Wu et al.
FRONTIERS IN PHARMACOLOGY (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
NADPH Oxidase-generated Hydrogen Peroxide Induces DNA Damage in Mutant FLT3-expressing Leukemia Cells
Joanna Stanicka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
Apolinar Maya-Mendoza et al.
MOLECULAR ONCOLOGY (2015)
Topoisomerase II and leukemia
MaryJean Pendleton et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
NADPH Oxidases: A Perspective on Reactive Oxygen Species Production in Tumor Biology
Jennifer L. Meitzler et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways
Yongqiang Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Nucleosomes Suppress the Formation of Double-strand DNA Breaks during Attempted Base Excision Repair of Clustered Oxidative Damages
Wendy J. Cannan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Causes and consequences of replication stress
Michelle K. Zeman et al.
NATURE CELL BIOLOGY (2014)
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Yan Ma et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Pancreatic cancer chemoprevention by phytochemicals
Srinivas Reddy Boreddy et al.
CANCER LETTERS (2013)
Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils
Ravi S. Keshari et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Replication fork collapse is a major cause of the high mutation frequency at three-base lesion clusters
Yuliya Sedletska et al.
NUCLEIC ACIDS RESEARCH (2013)
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
Chyuan-Chuan Wu et al.
NUCLEIC ACIDS RESEARCH (2013)
Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions
Rossella Marullo et al.
PLOS ONE (2013)
Anti-angiogenic activity of salvicine
Yanli Zhang et al.
PHARMACEUTICAL BIOLOGY (2013)
Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease
Marc Fransen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II
Viviane Brel et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Synthesis and antitumor activity of novel salvicine analogues
Fei Deng et al.
CHINESE CHEMICAL LETTERS (2011)
Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
Sophie E. Polo et al.
GENES & DEVELOPMENT (2011)
Reactive Oxygen Species (ROS)-Induced genetic and epigenetic alterations in human carcinogenesis
Dominique Ziech et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
The structural biochemistry of the superoxide dismutases
J. J. P. Perry et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy
Jinshui Fan et al.
BLOOD (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Cancer sternness and metastasis: Therapeutic consequences and perspectives
Joana Monteiro et al.
EUROPEAN JOURNAL OF CANCER (2010)
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair
Margret S. Fernandes et al.
BLOOD (2009)
Oxidative stress induces degradation of mitochondrial DNA
Inna Shokolenko et al.
NUCLEIC ACIDS RESEARCH (2009)
DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks
Carolin C. Schneider et al.
ONCOLOGY REPORTS (2009)
Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair
Annahita Sallmyr et al.
CANCER LETTERS (2008)
Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition
Yu-Jun Cai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Salvicine inactivates β1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling
Jin Zhou et al.
MOLECULAR CANCER RESEARCH (2008)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine
Yong-Wei Zhang et al.
MOLECULAR PHARMACOLOGY (2008)
Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells
Yujun Cai et al.
CANCER BIOLOGY & THERAPY (2007)
DNA topoisomerase II, genotoxicity, and cancer
A. Kathleen McClendon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Effects of α-tocopherol and β-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
Margaret E. Wright et al.
CANCER (2007)
Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways
Obdulio Piloto et al.
BLOOD (2007)
ATM and ATR - Components of an integrated circuit
Paula J. Hurley et al.
CELL CYCLE (2007)
Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes
Keisuke Ito et al.
JOURNAL OF IMMUNOLOGY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation
Ling-Hua Meng et al.
ACTA PHARMACOLOGICA SINICA (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Salvicine functions as novel topoisomerase II poison by binding to ATP pocket
Chao-Xin Hu et al.
MOLECULAR PHARMACOLOGY (2006)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Constitutively activated FLT3 phosphorylates BAD partially through Pim-1
Kyu-Tae Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
In vitro antiproliferative effect of six Salvia species on human tumor cell lines
Giovina Fiore et al.
PHYTOTHERAPY RESEARCH (2006)
Emerging cancer therapeutic opportunities target DNA-repair systems
Jian Ding et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase
HR Lu et al.
MOLECULAR PHARMACOLOGY (2005)
DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells
HR Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Role of the beta(1)-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells
C Heyder et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention
S Hsu et al.
ORAL ONCOLOGY (2004)
The role of reactive oxygen species in microcystin-LR-induced DNA damage
B Zegura et al.
TOXICOLOGY (2004)
Characterization of salvicine-resistant lung adenocarcinoma A549/SAL cell line
ZH Miao et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks
MO Nowicki et al.
BLOOD (2004)
Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells
WJ Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
In vivo EPR spectroscopy: biomedical and potential diagnostic applications
SK Jackson et al.
FARADAY DISCUSSIONS (2004)
Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193 - Implications for the repair of topoisomerase II-mediated DNA damage
N Adachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells
ZH Miao et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Oxidative DNA damage: mechanisms, mutation, and disease
MS Cooke et al.
FASEB JOURNAL (2003)
Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes
T Furuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis
WJ Liu et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
MF Fromm
ADVANCED DRUG DELIVERY REVIEWS (2002)
Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor
KF Tse et al.
LEUKEMIA (2002)
Cellular roles of DNA topoisomerases: A molecular perspective
JC Wang
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes
LH Meng et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells
LH Meng et al.
FEBS LETTERS (2001)
Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species
M Wartenberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation
HM Wang et al.
BIOCHEMISTRY (2001)
Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound
C Qing et al.
ANTI-CANCER DRUGS (2001)
Topoisomerase IIα expression in breast cancer:: Correlation with outcome variables
PL Depowski et al.
MODERN PATHOLOGY (2000)
DNA topoisomerase IIβ and neural development
X Yang et al.
SCIENCE (2000)